NVIDIA BioNeMo

freemium

NVIDIA BioNeMo provides pretrained AI models, open-source tools, and GPU-accelerated pipelines for drug discovery, genomics, protein structure prediction, and medical imaging.

AI Models & Infrastructure

Research & Education

LLM Developer Tools

About

NVIDIA BioNeMo is a specialized AI platform from NVIDIA tailored for healthcare, pharmaceutical, and life sciences organizations. It delivers a curated collection of pretrained foundation models—covering protein structure prediction, molecular docking, genomics, and medical imaging—alongside GPU-accelerated pipelines that can be fine-tuned and deployed at scale. Built on NVIDIA's Clara and DGX infrastructure, BioNeMo enables researchers and data scientists to develop AI-powered solutions for drug discovery, target identification, virtual screening, and digital biology. Users can access ready-to-use APIs to run inference on state-of-the-art biological models such as ESMFold, MolMIM, and DiffDock without managing underlying compute infrastructure. BioNeMo supports both cloud-based access via NVIDIA's API catalog and on-premises deployment for enterprise teams with strict data governance requirements. The platform integrates with popular ML frameworks and bioinformatics tools, lowering the barrier for domain scientists to leverage deep learning in their research pipelines. Key audiences include pharmaceutical companies accelerating drug pipelines, academic research institutions studying biomolecular systems, and AI engineers building next-generation healthcare applications. BioNeMo's combination of domain-specific pretrained models, scalable GPU infrastructure, and developer-friendly APIs makes it one of the most comprehensive AI platforms available for computational biology and life sciences innovation.

Key Features

Pretrained Biomolecular Foundation Models: Access state-of-the-art models like ESMFold, MolMIM, and DiffDock for protein structure prediction, molecular generation, and docking—ready to use via API or fine-tune on proprietary data.
GPU-Accelerated Pipelines: Run drug discovery, genomics, and medical imaging workflows on NVIDIA GPU infrastructure, dramatically reducing compute time compared to traditional CPU-based methods.
Cloud & On-Premises Deployment: Deploy BioNeMo models via NVIDIA's managed cloud API or within your own secure on-premises environment to meet enterprise data governance and compliance requirements.
Open-Source Tools & Frameworks: Leverage a growing library of open-source tools and integrations compatible with PyTorch, JAX, and major bioinformatics frameworks, enabling seamless adoption into existing research stacks.
Fine-Tuning & Custom Model Development: Fine-tune pretrained models on proprietary biological datasets to build highly specialized AI solutions tailored to specific therapeutic areas or research questions.

Use Cases

Pharmaceutical companies using AI-powered virtual screening to identify promising drug candidates faster and at lower cost than traditional wet-lab methods.
Computational biologists predicting protein structures and protein-ligand interactions to accelerate target identification and lead optimization in drug pipelines.
Genomics researchers running GPU-accelerated sequence analysis pipelines for variant calling, gene expression profiling, and multi-omics data integration.
Healthcare AI teams building and deploying medical imaging models for radiology, pathology, and diagnostic applications within compliant on-premises environments.
Academic research institutions fine-tuning large biomolecular foundation models on domain-specific datasets to explore novel biological hypotheses at scale.

Pros

World-Class Pretrained Models: BioNeMo bundles leading biomolecular AI models (protein folding, molecular docking, generative chemistry) that would otherwise require months of compute and expertise to train from scratch.
Backed by NVIDIA's GPU Ecosystem: Direct integration with NVIDIA DGX, HGX, and cloud GPU infrastructure ensures maximum performance and scalability for computationally intensive life sciences workloads.
Flexible Deployment Options: Supports both cloud API access for rapid prototyping and on-premises deployment for regulated industries that require data sovereignty.
Broad Life Sciences Coverage: Covers a wide range of domains—drug discovery, protein biology, genomics, and medical imaging—making it a comprehensive platform for diverse healthcare AI use cases.

Cons

High Cost at Enterprise Scale: Full enterprise access with dedicated GPU resources can be prohibitively expensive for smaller academic labs or early-stage startups without significant compute budgets.
Steep Learning Curve for Non-AI Scientists: Domain scientists without a strong machine learning background may find the platform challenging to adopt without dedicated ML engineering support.
NVIDIA Hardware Dependency: Optimal performance requires NVIDIA GPUs; teams relying on alternative hardware (AMD, cloud TPUs) may face compatibility and performance limitations.

Frequently Asked Questions

NVIDIA BioNeMo is used for AI-driven life sciences research, including drug discovery, protein structure prediction, molecular generation, genomics analysis, and medical imaging. It provides pretrained models and GPU-accelerated pipelines that help researchers and pharmaceutical companies accelerate their workflows.

BioNeMo offers free API access with limited usage through NVIDIA's API catalog, allowing researchers to test and prototype with pretrained models. Full enterprise-scale access with dedicated GPU infrastructure is available as a paid service.

BioNeMo includes a growing collection of biomolecular foundation models such as ESMFold (protein structure prediction), MolMIM (molecular generation), DiffDock (molecular docking), and various genomics and medical imaging models.

Yes. BioNeMo supports on-premises deployment on NVIDIA DGX systems and compatible GPU servers, making it suitable for pharmaceutical and healthcare organizations that require data governance and do not wish to send sensitive data to the cloud.

BioNeMo is designed for computational biologists, AI researchers, data scientists, and ML engineers working in pharmaceutical, biotech, academic, and healthcare organizations. It is particularly valuable for teams working on drug discovery, protein engineering, and genomics at scale.